Income Tax Expense (Benefit) of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. from 27 Mar 2010 to 27 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 27 Mar 2010 to 27 Dec 2025.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Income Tax Expense (Benefit) for the quarter ending 27 Dec 2025 was $17,809,000, a 485% decline year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Income Tax Expense (Benefit) for the twelve months ending 27 Dec 2025 was $42,660,000, a 37% decline year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Income Tax Expense (Benefit) for 2025 was $42,660,000, a 37% decline from 2024.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Income Tax Expense (Benefit) for 2024 was $67,823,000, a 33% decline from 2023.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Income Tax Expense (Benefit) for 2023 was $100,914,000, a 23% decline from 2022.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$42,660,000	$17,809,000	-$14,765,000	-485%	28 Sep 2025	27 Dec 2025	10-K	18 Feb 2026	2025	FY
Q3 2025	$57,425,000	$31,644,000	+$10,698,000	+51%	29 Jun 2025	27 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$46,727,000	$18,725,000	-$6,667,000	-26%	30 Mar 2025	28 Jun 2025	10-Q	06 Aug 2025	2025	Q2
Q1 2025	$53,394,000	$10,100,000	-$14,429,000	-59%	29 Dec 2024	29 Mar 2025	10-Q	07 May 2025	2025	Q1
Q4 2024	$67,823,000	$3,044,000	-$22,798,000	-115%	29 Sep 2024	28 Dec 2024	10-K	18 Feb 2026	2025	FY
Q3 2024	$90,621,000	$20,946,000	-$3,906,000	-16%	30 Jun 2024	28 Sep 2024	10-Q	05 Nov 2025	2025	Q3
Q2 2024	$94,527,000	$25,392,000	-$3,829,000	-13%	31 Mar 2024	29 Jun 2024	10-Q	06 Aug 2025	2025	Q2
Q1 2024	$98,356,000	$24,529,000	-$2,558,000	-9.4%	31 Dec 2023	30 Mar 2024	10-Q	07 May 2025	2025	Q1
Q4 2023	$100,914,000	$19,754,000	-$36,061,000	-65%	01 Oct 2023	30 Dec 2023	10-K	18 Feb 2026	2025	FY
Q3 2023	$136,975,000	$24,852,000	-$643,000	-2.5%	02 Jul 2023	30 Sep 2023	10-Q	06 Nov 2024	2024	Q3
Q2 2023	$137,618,000	$29,221,000	-$4,228,000	-13%	02 Apr 2023	01 Jul 2023	10-Q	07 Aug 2024	2024	Q2
Q1 2023	$141,846,000	$27,087,000	+$11,467,000	+73%	01 Jan 2023	01 Apr 2023	10-Q	09 May 2024	2024	Q1
Q4 2022	$130,379,000	$55,815,000	+$32,000,000	+134%	25 Sep 2022	31 Dec 2022	10-K	19 Feb 2025	2024	FY
Q3 2022	$98,379,000	$25,495,000	+$7,384,000	+41%	26 Jun 2022	24 Sep 2022	10-Q	08 Nov 2023	2023	Q3
Q2 2022	$90,995,000	$33,449,000	-$4,131,000	-11%	27 Mar 2022	25 Jun 2022	10-Q	09 Aug 2023	2023	Q2
Q1 2022	$95,126,000	$15,620,000	+$13,253,000	+560%	26 Dec 2021	26 Mar 2022	10-Q	11 May 2023	2023	Q1
Q4 2021	$81,873,000	$23,815,000	-$4,422,000	-16%	26 Sep 2021	25 Dec 2021	10-K	14 Feb 2024	2023	FY
Q3 2021	$86,295,000	$18,111,000	-$14,554,000	-45%	27 Jun 2021	25 Sep 2021	10-Q	02 Nov 2022	2022	Q3
Q2 2021	$100,849,000	$37,580,000	+$21,296,000	+131%	28 Mar 2021	26 Jun 2021	10-Q	03 Aug 2022	2022	Q2
Q1 2021	$79,553,000	$2,367,000	-$2,255,000	-49%	27 Dec 2020	27 Mar 2021	10-Q	04 May 2022	2022	Q1
Q4 2020	$81,808,000	$28,237,000	+$3,184,000	+13%	27 Sep 2020	26 Dec 2020	10-K	22 Feb 2023	2022	FY
Q3 2020	$78,624,000	$32,665,000	+$32,982,000		28 Jun 2020	26 Sep 2020	10-Q	03 Nov 2021	2021	Q3
Q2 2020	$45,642,000	$16,284,000	+$1,599,000	+11%	29 Mar 2020	27 Jun 2020	10-Q	04 Aug 2021	2021	Q2
Q1 2020	$44,043,000	$4,622,000	-$5,980,000	-56%	29 Dec 2019	28 Mar 2020	10-Q	04 May 2021	2021	Q1
Q4 2019	$50,023,000	$25,053,000	+$10,203,000	+69%	29 Sep 2019	28 Dec 2019	10-K	16 Feb 2022	2021	FY
Q3 2019	$39,820,000	$317,000	-$12,720,000	-103%	30 Jun 2019	28 Sep 2019	10-Q	29 Oct 2020	2020	Q3
Q2 2019	$52,540,000	$14,685,000	-$2,753,000	-16%	31 Mar 2019	29 Jun 2019	10-Q	05 Aug 2020	2020	Q2
Q1 2019	$55,293,000	$10,602,000	+$830,000	+8.5%	30 Dec 2018	30 Mar 2019	10-Q	07 May 2020	2020	Q1
Q4 2018	$54,463,000	$14,850,000	-$83,247,000	-85%	30 Sep 2018	29 Dec 2018	10-K	17 Feb 2021	2020	FY
Q3 2018	$137,710,000	$12,403,000	-$7,542,000	-38%	01 Jul 2018	29 Sep 2018	10-Q	06 Nov 2019	2019	Q3
Q2 2018	$145,252,000	$17,438,000	-$4,805,000	-22%	01 Apr 2018	30 Jun 2018	10-Q	31 Jul 2019	2019	Q2
Q1 2018	$150,057,000	$9,772,000	-$21,312,000	-69%	31 Dec 2017	31 Mar 2018	10-Q	07 May 2019	2019	Q1
Q4 2017	$171,369,000	$98,097,000	+$79,647,000	+432%	01 Oct 2017	30 Dec 2017	10-K	11 Feb 2020	2019	FY
Q3 2017	$91,722,000	$19,945,000	+$4,380,000	+28%	02 Jul 2017	30 Sep 2017	10-Q	07 Nov 2018	2018	Q3
Q2 2017	$87,342,000	$22,243,000	+$3,398,000	+18%	02 Apr 2017	01 Jul 2017	10-Q	08 Aug 2018	2018	Q2
Q1 2017	$83,944,000	$31,084,000	+$17,109,000	+122%	01 Jan 2017	01 Apr 2017	10-Q	10 May 2018	2018	Q1
Q4 2016	$66,835,000	$18,450,000	+$1,721,000	+10%	25 Sep 2016	31 Dec 2016	10-K	13 Feb 2019	2018	FY
Q3 2016	$65,114,000	$15,565,000	+$310,000	+2%	26 Jun 2016	24 Sep 2016	10-Q	09 Nov 2017	2017	Q3
Q2 2016	$64,804,000	$18,845,000	+$7,769,000	+70%	27 Mar 2016	25 Jun 2016	10-Q	09 Aug 2017	2017	Q2
Q1 2016	$57,035,000	$13,975,000	+$13,644,000	+4122%	27 Dec 2015	26 Mar 2016	10-Q	10 May 2017	2017	Q1
Q4 2015	$43,391,000	$16,729,000	+$5,079,000	+44%	27 Sep 2015	26 Dec 2015	10-K	13 Feb 2018	2017	FY
Q3 2015	$38,312,000	$15,255,000	+$3,673,000	+32%	28 Jun 2015	26 Sep 2015	10-Q	02 Nov 2016	2016	Q3
Q2 2015	$34,639,000	$11,076,000	-$3,005,000	-21%	29 Mar 2015	27 Jun 2015	10-Q	03 Aug 2016	2016	Q2
Q1 2015	$37,644,000	$331,000	-$10,027,000	-97%	28 Dec 2014	28 Mar 2015	10-Q	04 May 2016	2016	Q1
Q4 2014	$47,671,000	$11,650,000	+$8,070,000	+225%	28 Sep 2014	27 Dec 2014	10-K	14 Feb 2017	2016	FY
Q3 2014	$39,601,000	$11,582,000	+$192,000	+1.7%	29 Jun 2014	27 Sep 2014	10-Q	04 Nov 2015	2015	Q3
Q2 2014	$39,409,000	$14,081,000	+$5,862,000	+71%	30 Mar 2014	28 Jun 2014	10-Q	30 Jul 2015	2015	Q2
Q1 2014	$33,547,000	$10,358,000	+$636,000	+6.5%	29 Dec 2013	29 Mar 2014	10-Q	30 Apr 2015	2015	Q1
Q4 2013	$32,911,000	$3,580,000	+$92,000	+2.6%	29 Sep 2013	28 Dec 2013	10-K	12 Feb 2016	2015	FY
Q3 2013	$32,819,000	$11,390,000	+$5,379,000	+89%	30 Jun 2013	28 Sep 2013	10-Q	30 Oct 2014	2014	Q3
Q2 2013	$27,440,000	$8,219,000	-$1,234,000	-13%	31 Mar 2013	29 Jun 2013	10-Q	07 Aug 2014	2014	Q2
Q1 2013	$28,674,000	$9,722,000	+$1,046,000	+12%	30 Dec 2012	30 Mar 2013	10-Q	30 Apr 2014	2014	Q1
Q4 2012	$27,628,000	$3,488,000	-$2,088,000	-37%	30 Sep 2012	29 Dec 2012	10-K	17 Feb 2015	2014	FY
Q3 2012	$29,716,000	$6,011,000	+$381,000	+6.8%	01 Jul 2012	29 Sep 2012	10-Q	30 Oct 2013	2013	Q3
Q2 2012	$29,335,000	$9,453,000	+$804,000	+9.3%	01 Apr 2012	30 Jun 2012	10-Q	31 Jul 2013	2013	Q2
Q1 2012	$28,531,000	$8,676,000	+$11,391,000		01 Jan 2012	31 Mar 2012	10-Q	08 May 2013	2013	Q1
Q4 2011	$17,140,000	$5,576,000			25 Sep 2011	31 Dec 2011	10-K	25 Feb 2014	2013	FY
Q3 2011		$5,630,000	-$11,040,000	-66%	26 Jun 2011	24 Sep 2011	10-Q	01 Nov 2012	2012	Q3
Q2 2011		$8,649,000	+$1,479,000	+21%	27 Mar 2011	25 Jun 2011	10-Q	07 Aug 2012	2012	Q2
Q1 2011		$2,715,000	-$9,452,000	-140%	26 Dec 2010	26 Mar 2011	10-Q	04 May 2012	2012	Q1
Q3 2010		$16,670,000			27 Jun 2010	25 Sep 2010	10-Q	02 Nov 2011	2011	Q3
Q2 2010		$7,170,000			28 Mar 2010	26 Jun 2010	10-Q	03 Aug 2011	2011	Q2
Q1 2010		$6,737,000			27 Dec 2009	27 Mar 2010	10-Q	04 May 2011	2011	Q1

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Annual Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$42,660,000	-$25,163,000	-37%	29 Dec 2024	27 Dec 2025	10-K	18 Feb 2026	2025	FY
2024	$67,823,000	-$33,091,000	-33%	31 Dec 2023	28 Dec 2024	10-K	18 Feb 2026	2025	FY
2023	$100,914,000	-$29,465,000	-23%	01 Jan 2023	30 Dec 2023	10-K	18 Feb 2026	2025	FY
2022	$130,379,000	+$48,506,000	+59%	26 Dec 2021	31 Dec 2022	10-K	19 Feb 2025	2024	FY
2021	$81,873,000	+$65,000	+0.08%	27 Dec 2020	25 Dec 2021	10-K	14 Feb 2024	2023	FY
2020	$81,808,000	+$31,785,000	+64%	29 Dec 2019	26 Dec 2020	10-K	22 Feb 2023	2022	FY
2019	$50,023,000	-$4,440,000	-8.2%	30 Dec 2018	28 Dec 2019	10-K	16 Feb 2022	2021	FY
2018	$54,463,000	-$116,906,000	-68%	31 Dec 2017	29 Dec 2018	10-K	17 Feb 2021	2020	FY
2017	$171,369,000	+$104,534,000	+156%	01 Jan 2017	30 Dec 2017	10-K	11 Feb 2020	2019	FY
2016	$66,835,000	+$23,444,000	+54%	27 Dec 2015	31 Dec 2016	10-K	13 Feb 2019	2018	FY
2015	$43,391,000	-$4,280,000	-9%	28 Dec 2014	26 Dec 2015	10-K	13 Feb 2018	2017	FY
2014	$47,671,000	+$14,760,000	+45%	29 Dec 2013	27 Dec 2014	10-K	14 Feb 2017	2016	FY
2013	$32,911,000	+$5,283,000	+19%	30 Dec 2012	28 Dec 2013	10-K	12 Feb 2016	2015	FY
2012	$27,628,000	+$10,488,000	+61%	01 Jan 2012	29 Dec 2012	10-K	17 Feb 2015	2014	FY
2011	$17,140,000	+$17,117,000		26 Dec 2010	31 Dec 2011	10-K	25 Feb 2014	2013	FY
2010	$23,000^*			27 Dec 2009	25 Dec 2010	10-K	27 Feb 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.